$12.5 million awarded to Montreal team to study Parkinson’s Disease
A group of scientists at University of Montreal, The Neuro (Montreal Neurological Institute-Hospital), and 91˿Ƶ has been awarded a major research grant of over $12.5 million from the Aligning Science Across Parkinson’s (ASAP) initiative over the next three years to study Parkinson’s disease. ASAP’s implementation partner The Michael J Fox Foundation for Parkinson’s Research issued the grant.
Molecular alterations in neuronal trophic regulation in Alzheimer’s pathology begin decades before detectable cognitive impairments
Findings could lead to development of pre-clinical stage therapeutics
By Jason Clement
Game-changing blood test accurately detects Alzheimer’s disease
91˿Ƶ-Gothenburg collaboration yields affordable test that could revolutionize the way AD is diagnosed, studied and treated
By Gillian Woodford
COVID-19: Faculty of Medicine Update 2020/04/05 - Message from VP-Dean Eidelman - Faculty Council Takeaways and FAQs
To all members of the Faculty of Medicine, including learners and staff,
COVID-19: Faculty of Medicine Update 2020/03/23 - Message from VP-Dean Eidelman
To all members of the Faculty of Medicine, including learners and staff,
COVID-19: Faculty of Medicine Update 2020/03/14 - Status
To all members of the Faculty, including all learners and staff,
COVID-19: Faculty of Medicine Update 2020/03/12 - Faculty-hosted conferences, events
To all members of the Faculty of Medicine, including all learners:
91˿Ƶ is closely monitoring the COVID-19 situation as it continues to rapidly evolve. When providing the community with advice, the University is following the guidelines of Quebec and Canada’s Public Health authorities. As members of the Faculty and health care system, we must exercise extra vigilance to contain the spread of the virus.
COVID-19: Faculty of Medicine Update 2020/03/11 - MSSS directive regarding learners, travel, conferences
To all members of the Faculty of Medicine, including all learners:
Getting off of the blood sugar roller coaster
91˿Ƶ researchers are pioneering a new artificial pancreas system that provides life-changing support to people living with type 1 diabetes.
By Ashley Rabinovitch
Vitamin E effective, safe for fatty liver in HIV patients
ByGillian Woodford
A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a 91˿Ƶ-led study has found.
Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer.
How many gender subtypes exist in the brain?
New machine learning study suggest the presence of at least nine gender “expressions”
Beyond the Pap Smear
91˿Ƶ researchers identify new markers for early detection of cervical cancer
By Ashley Rabinovitch
Can Exercise Improve Video Game Performance?
By Monica Slanik, School of Physical and Occupational Therapy
Can lithium halt progression of Alzheimer’s disease?
91˿Ƶ researchers’ findings show that may be the case
91˿Ƶ PhD student named to Forbes Top 30 under 30 list
Daniel Almeida, a PhD student under the supervision of Dr. Gustavo Turecki in 91˿Ƶ’s Integrated Program in Neuroscience and at the Douglas Research Centre, was included in Forbes Magazine’s Top 30 under 30 list, unveiled December 3. Overall, the ninth annual list includes 600 young entrepreneurs, risk-takers and game changers who are redefining what it means to innovate and lead by example.